A phase I–II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia
Titel:
A phase I–II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia
Auteur:
Martínez-Cuadrón, David Boluda, Blanca Martínez, Pilar Bergua, Juan Rodríguez-Veiga, Rebeca Esteve, Jordi Vives, Susana Serrano, Josefina Vidriales, Belen Salamero, Olga Cordón, Lourdes Sempere, Amparo Jiménez-Ubieto, Ana Prieto-Delgado, Julio Díaz-Beyá, Marina Garrido, Ana Benavente, Celina Pérez-Simón, José Antonio Moscardó, Federico Sanz, Miguel A. Montesinos, Pau